Intermediate clinical endpoints in localised prostate cancer.

Tree, Alison C; Dearnaley, David P; Hall, Emma

Tree, Alison C; Dearnaley, David P; Hall, Emma.

Tree AC; Urology Unit, The Royal Marsden NHS Foundation Trust, The Institute of Cancer Research, London SM2 5PT, UK; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London SM2 5PT, UK.
Dearnaley DP; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London SM2 5PT, UK. Electronic address: david.dearnaley@icr.ac.uk.
Hall E; Clinical Trials and Statistics Unit, The Institute of Cancer Research, London SM2 5PT, UK.

Lancet Oncol ; 22(3): 294-296, 2021 03.

Article in English | MEDLINE | ID: covidwho-1111907

Subject(s)

Prostatic Neoplasms; Humans; Male; Prostatectomy; Prostatic Neoplasms/surgery

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Prostatic Neoplasms Type of study: Prognostic study Limits: Humans / Male Language: English Journal: Lancet Oncol Journal subject: Neoplasms Year: 2021 Document Type: Article Affiliation country: S1470-2045(21)00025-5

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google